600511.SH
国药股份
SSE · Healthcare · Medical - Distribution · CN
CNY 26.26
−0.53%Year over year
Reported trailing growth
- Revenue
- +4.1%
- EBITDA
- —
- EBIT
- -1.4%
- EPS
- +0.6%
- Free cash flow
- -82.6%
- Operating cash flow
- -79.4%
Forward estimates
Based on analyst estimates
- Revenue
- -75.1%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- -0.6%
- EBIT
- -0.9%
- Net income
- +0.5%
- EPS
- +0.5%
- Free cash flow
- -5.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026